Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer - Concepedia

Concepedia

Publication | Open Access

Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

DOI Full Paper Access

307

Citations

20

References

2006

Year

Patrick J. Perik, Marjolijn N. Lub–de Hooge, Jourik A. Gietema, Winette T.A. van der Graaf, M.A. de Korte, S. Jonkman, Jos G. W. Kosterink, Dirk J. van Veldhuisen, Dirk Th. Sleijfer, Pieter L. Jager,

Journal of Clinical Oncology

Abstract

Radiolabeled trastuzumab scintigraphy was not valuable in predicting trastuzumab-related cardiotoxicity in metastatic breast cancer patients, but can identify HER2-positive tumors. Measurement of plasma NT-proBNP is promising regarding prediction of trastuzumab-related cardiotoxicity.

References

	Year	Citations

Page 1